VAERS Explorer
Back to explore

Report #2896501

Received May 14, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
Recovered
Not recovered
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK

Symptoms (2)

ArthralgiaInjection site pain

Symptom narrative

soreness in arm at the injection site; entire shoulder is in pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 68-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: soreness in arm at the injection site) and shoulder pain (Verbatim: entire shoulder is in pain). The outcome of the injection site pain and shoulder pain were not resolved. It was unknown if the reporter considered the injection site pain and shoulder pain to be related to Shingrix. It was unknown if the company considered the injection site pain and shoulder pain to be related to Shingrix. Additional Information: GSK receipt Date: 05-MAY-2026 The reporter wanted to know if he/she could apply heat or take Advil.